Spine Biologics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-1633 | Report Format : | Status : Upcoming |

Abstract

Global Spine Biologics Market: Overview

Spine biologics is a treatment that is used during the spine fusion surgery for the treatment of spinal deformities that include spinal cord injuries, trauma, degenerative disc disease, and tumors. It stimulates the growth of the bone formation through different stages which include inflammatory, repair, and remodeling. Spine biologics is used in the treatment of symptomatic deformity to achieve successful arthrodesis. Spine biologics is a minimally invasive method and it requires less time as compared to that of open surgical procedures.

Global Spine Biologics Market: Growth Factors

Major factors that are driving the spine biologics market growth include a rise in the number of geriatric population, benefits provided by spine biologics is faster recovery, minimal postoperative time, and ability to activate cellular growth. Spinal disorders are most common in men and women over 50 years. Spinal injuries can be due to the enlargement of bones & joints, thickening of the band of the tissue, which supports the spine. This is the key factor that is fuelling the market growth in the coming years. People who are at the high risk of spinal deformities need to undergo spinal fusion surgery thus increasing its demand in the global market. However, higher cost of the bone grafts, hostile reimbursement scenario, and concerns regarding the bone grafting procedures is expected to hamper the global spine biologics market growth.

Global Spine Biologics Market: Segmentation

The spine biologics market is segmented on the basis of product, surgery, and region. The product segment is classified into the cell based matrix, spinal allografts, platelet rich plasma, and bone graft substitutes. The spinal allografts segment is sub-segmented into the demineralized bone matrix and machined bones allograft. The bone graft substitute is sub-segmented into synthetic bone grafts and bone morphogenetic proteins. Depending on the surgery, the market is divided into anterior cervical discectomy and fusion, lateral lumbar interbody fusion, transforaminal lumbar interbody fusion, anterior lumbar interbody fusion, and other surgeries. The region wise breakdown of the market includes North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Global Spine Biologics Market: Regional Analysis

North America contributed the largest market share in the global spine biologics market due to stable economic growth. North America is followed by Europe. Other factors influencing the market are an increase in the disposal income, growing population, improved medical literacy, and raising awareness regarding newly developed technologies. Spine biologics has a tremendous demand from the regions of America owing to the advancement in the technology and large pool of the patients. The market in Asia Pacific is experiencing growth in the market owing to increase in the patient pool, advanced rheumatoid arthritis and osteoarthritis procedure, availability of the sophisticated diagnostic technique, and growing awareness among the people. Emerging economies such as China, India, Korea, Thailand, and Vietnam are supporting the market due to economic growth, high prevalence, fast disease progression, improving healthcare facility, and insurance coverage.

Global Spine Biologics Market: Competitive Players

Major companies operating in the global spine biologics market are Exactech, Inc., Alphatec Holdings, Inc., Globus Medical, Depuy Synthes, Inc., and Zimmer Biomet Holdings, Inc. Other prominent players include RTI Surgical, Inc., Medtronic Plc., Xtant Medical., Orthofix International N.V., NuVasive, Inc., Nutech, SeaSpine, and Life Spine, Inc.

Global Spine Biologics Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Immuno-oncology Therapy Market by Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors (PD-1/PD-L1 and CTLA-4), Immune System Modulators, and Cancer Vaccines) and by Therapeutic Areas, for Hospitals, Clinics, ASC’s and Cancer Research Institutes: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Jan-2018 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2534 | Report Format:

The report covers forecast and analysis for the immuno-oncology therapy market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the immuno-oncology therapy mar...Read More

Compounding Pharmacies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2525 | Report Format:

Global Compounding Pharmacies Market: Overview Compounding is the knowledge of preparing and combining tailored medicines for users. These medicines are made on the basis of the prescription from the practitioner wherein, the separate ingredients are blended together according to the recommended...Read More

Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2514 | Report Format:

The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the antithrombin market along with the imp...Read More

Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine and Combined Drug), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Sales), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2513 | Report Format:

The report covers forecast and analysis for the Alzheimers drugs market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the Alzheimers drugs market along ...Read More

Non-Invasive Prenatal Testing (NIPT) Market by Test Type (Panel 1, Panel 2 and Panel 3) and End-users (Hospitals, Diagnostic Centers and Maternity Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2512 | Report Format:

The report covers forecast and analysis for the non-invasive prenatal testing (NIPT) market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the non-invasive p...Read More

Choose License Type:
Latest Published Reports

View All Published Reports